Ranbaxy Launches Generic Clarithromycin After Defeating Abbott In U.K. Court
Indian drug maker Ranbaxy Laboratories Ltd. has a launched a generic version of the anti-infective drug clarithromycin in the U.K. after winning a patent infringement lawsuit brought by U.S.-based Abbott Laboratories....To view the full article, register now.
Already a subscriber? Click here to view full article